December 10 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev acquired 10,000 shares in the company through deals priced at 3.10 levs ($1.93/1.59 euro) per share on December 9.